Detalhe da pesquisa
1.
Transcriptional signature of early cisplatin drug-tolerant persister cells in lung adenocarcinoma.
Front Oncol
; 13: 1208403, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916165
2.
Partners in crime: The feedback loop between metabolic reprogramming and immune checkpoints in the tumor microenvironment.
Front Oncol
; 12: 1101503, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36713558
3.
The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment.
Front Endocrinol (Lausanne)
; 13: 929572, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36072935
4.
Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines.
Front Oncol
; 11: 750677, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34966671
5.
Old and New Players of Inflammation and Their Relationship With Cancer Development.
Front Oncol
; 11: 722999, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34881173
6.
The Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Pro-tumor Activity.
Front Oncol
; 10: 578418, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33117715